Abzena, located in Bristol, PA, is a leading bioconjugate and complex biologics CDMO CRO that specializes in developing and implementing fully integrated and tailored solutions for the development and manufacture of novel treatments. Their experienced scientists work closely with clients to challenge assumptions, bring new ideas to the table, and navigate drug programs toward regulatory approval efficiently.
With a focus on de-risking and streamlining the development process, Abzena collaborates with pharmaceutical companies to advance technology and programs, providing high-quality data and insights to accelerate the delivery of medicines to patients in need. Their expertise in complex biologics and bioconjugation development makes them a valuable partner in bridging the gap from discovery to commercial launch.
Generated from the website